Skip to content
★ Sign in to follow
Total declarations
12
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (8 ops.)
€1.5M

Latest filing published 05 Nov 2019 for Twist Bioscience Corp.

Filing timeline

BuySale
Bill Peck

Insider track record

Disclosed buys
0
Disclosed sells
8
Signal history

Bill Peck: trading record in brief

This profile gathers the share dealings of Bill Peck in Twist Bioscience Corp. We count 12 filings; the first trade dates from 19 November 2018 and the latest from 1 November 2019.

No open-market purchase appears, only 8 sales worth €1.5M. Besides market trades, the filings include 2 share grants. 2019 to date brings no purchases and 8 sales.

The newest entry dates from 5 November 2019: a transaction of €96k, in Twist Bioscience Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Bill Peck

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total
  • ◆
    Chief Technology OfficerExecutivesTwist Bioscience Corp
    0SEC
    2,780 shares0Common StockSEC:0001209191-19-055411:0
  • ●
    Chief Technology OfficerExecutivesTwist Bioscience Corp
    106,588 USD11SEC
    4,363 shares@ US$24.434.9% of flowCommon StockSEC:0001209191-19-055411:1
  • ●
    Chief Technology OfficerExecutivesTwist Bioscience Corp
    392,489 USD13SEC
    15,637 shares@ US$25.1018.2% of flowCommon StockSEC:0001209191-19-055411:2
  • ▼
    Chief Technology OfficerExecutivesTwist Bioscience Corp
    279,333 USD30SEC
    12,300 shares@ US$22.7113.2% of flowCommon StockSEC:0001209191-19-052203:0
  • ▼
    Chief Technology OfficerExecutivesTwist Bioscience Corp
    180,804 USD30SEC
    7,600 shares@ US$23.798.5% of flowCommon StockSEC:0001209191-19-052203:1
  • ▼
    Chief Technology OfficerExecutivesTwist Bioscience Corp
    2,436 USD29SEC
    100 shares@ US$24.360.1% of flowCommon StockSEC:0001209191-19-052203:2
  • ▼
    Chief Technology OfficerExecutivesTwist Bioscience Corp
    12,000 USD29SEC
    400 shares@ US$30.000.6% of flowCommon StockSEC:0001209191-19-049887:0
  • ▼
    Chief Technology OfficerExecutivesTwist Bioscience Corp
    575,739 USD32SEC
    19,153 shares@ US$30.0627.0% of flowCommon StockSEC:0001209191-19-049887:1
  • ▼
    Chief Technology OfficerExecutivesTwist Bioscience Corp
    320,310 USD31SEC
    11,493 shares@ US$27.8715.1% of flowCommon StockSEC:0001209191-19-048633:0
  • ▼
    Chief Technology OfficerExecutivesTwist Bioscience Corp
    187,720 USD30SEC
    6,500 shares@ US$28.888.8% of flowCommon StockSEC:0001209191-19-048633:1
  • ▼
    Chief Technology OfficerExecutivesTwist Bioscience Corp
    73,178 USD29SEC
    2,454 shares@ US$29.823.4% of flowCommon StockSEC:0001209191-19-048633:2
  • ◆
    Chief Technology OfficerExecutivesTwist Bioscience Corp
    0SEC
    15,002 shares0Common StockSEC:0001209191-18-059801:0

12 of 12 declarations